Sleiman, S. F., Langley, B. C., Berlin, J., Xia, L., Payappilly, J. B., Kharel, M. K., . . . Ratan, R. R. (2011). Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.
Chicago Style (17th ed.) CitationSleiman, Sama F., et al. Mithramycin Is a Gene-selective Sp1 Inhibitor That Identifies a Biological Intersection Between Cancer and Neurodegeneration. 2011.
MLA (9th ed.) CitationSleiman, Sama F., et al. Mithramycin Is a Gene-selective Sp1 Inhibitor That Identifies a Biological Intersection Between Cancer and Neurodegeneration. 2011.
Warning: These citations may not always be 100% accurate.